Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008
Lack of glucocorticoid receptor activation by formoterol and salmeterol in human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003
Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
Azithromycin induces anti-viral responses in bronchial epithelial cells Source: Eur Respir J 2010; 36: 646-654 Year: 2010
Differential effects of budesonide and fluticasone propionate on immune defense genes in human bronchial epithelium Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
Budesonide and formoterol inhibit bronchial epithelial cell-mediated eosinophil superoxide production Source: Eur Respir J 2005; 26: Suppl. 49, 123s Year: 2005
Budesonide esterification in human bronchial epithelial cells is not impaired by formoterol Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002
Lack of effect of beclomethasone dipropionate on EGF-R expression in human nasal epithelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 245s Year: 2001
Effect of beclomethasone dipropionate, formoterol and their combination on TNF-α-induced ICAM-1 and IL-8 expression in human bronchial epithelial cells Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 39s Year: 2003
Fluticasone furoate restores leptin/leptin receptor pathway in nasal epithelial cells Source: Annual Congress 2011 - Lung cell biology Year: 2011
Inhibitory activities of fluticasone propionate and salmeterol on airway epithelial cell functions (FLIC24): adhesion molecule expression and cytokine release Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001
Combination of budesonide and formoterol is more effective in inhibiting GM-CSF production by bronchial epithelial cells than either drug alone Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003
Attenuated cytokine response and enhanced toll-like receptor expression by budesonide in bronchial epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006
Fluticasone propionate decreases MUC5AC expression on airway epithelial cells induced by rhinovirus infection in the airway Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013
Role of innate lymphoid cells and the epithelium in asthma and bronchoconstriction Source: International Congress 2018 – It's my favourite cell that affects your asthma Year: 2018
Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004